Chiusura precedente | 2,0500 |
Aperto | 2,0600 |
Denaro | 2,1500 x 2400 |
Lettera | 2,2400 x 300 |
Min-Max giorno | 1,9850 - 2,2100 |
Intervallo di 52 settimane | 1,5100 - 13,3100 |
Volume | |
Media Volume | 5.846.481 |
Capitalizzazione | 172,422M |
Beta (5 anni mensile) | 1,78 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -4,1700 |
Prossima data utili | 25 lug 2024 - 29 lug 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | 25 set 2013 |
Stima target 1A | 5,02 |
Complete weight health platform with individualized pathways inclusive of both behavioral and clinical interventions and science-proven tools for employers and health plansNEW YORK, Oct. 06, 2023 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers for Business has fully integrated WW’s science-proven behavioral program with its virtual obesity clinic and medication management. The Company now offers a full spectrum weigh
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conferences. Baird 2023 Global Healthcare ConferenceTuesday, September 12, 2023 at 4:55 pm ET New York, NYPresenters: Heather Stark, Chief Financial Officer and Gary Foster, PhD, Chief Scientific Officer Morgan Stanley 21st Annual Global Healthcare ConferenceWednesday, September 13, 2023 at 3:35 pm ETNew York, N
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW), known as WeightWatchers, announced today that William Shrank, MD, MSHS, Venture Partner of Bio and Health at Andreessen Horowitz, and former Chief Medical Officer at Humana, has been appointed to the WeightWatchers Board of Directors, effective as of August 5, 2023. "It is a pleasure to welcome Dr. Shrank to the board," said Thilo Semmelbauer, Chairman of the Board of WeightWatchers. “Dr. Shrank brings a wide range